The Danish Competition Authority approves a merger between two national pharmaceutical companies subject to conditions (Orifarm / Takeda)

The Danish Competition Council has approved Orifarm’s acquisition of certain assets from Takeda subject to commitments* The Danish Competition Council has approved Orifarm Generics Holding’s (hereinafter “Orifarm”) acquisition of certain assets, including a product portfolio consisting of prescription pharmaceuticals, over-the-counter pharmaceuticals, vitamin and

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Danish Competition Authority, The Danish Competition Authority approves a merger between two national pharmaceutical companies subject to conditions (Orifarm / Takeda), 24 March 2021, e-Competitions February 2021, Art. N° 99885

Visites 225

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues